Shlomo Greenberg
Shlomo Greenberg
Stop FollowingShlomo Greenberg
View as an RSS Feed
View Shlomo Greenberg's Articles BY TICKER:
ALA,
ALDN,
ALJ,
ALLT,
ALSC.PK,
ALU,
ALVR,
AMGN,
ANSW,
ARTX,
AUDC,
BAM,
BMY,
BOSC,
BPA,
BPHX,
BWEBF.PK,
CALL,
CAMT,
CGEN,
CHKP,
CIEN,
CIMT,
CKSW,
CMVT,
CRNT,
CSCO,
CTCH,
DDDC.PK,
DK,
DOX,
DSPG,
DTV,
ECIL,
ECTX,
ELOS,
ELRN,
ELTK,
EMITF,
EQY,
ESLT,
EZCH,
FFIV,
FLSH,
FORTY,
GILT,
GIVN,
GLOB,
HCTL,
HLIT,
IFNNY.PK,
INTC,
IXMOE.OB,
JNPR,
KERX,
LLL,
LUME.PK,
MAT,
MDTL.PK,
MERQ,
MGIC,
MLS,
MNDO,
MRK,
MRVL,
MTLK,
MXICY.PK,
NICE,
NNDS,
NSTC,
NT,
NWS,
OMRI,
ORA,
ORBK,
OTIV,
PARS,
PLX,
PNTR,
QCOM,
RADA,
RHHBY.PK,
ROSG,
RTLX,
RVSN,
SCOP,
SFUN,
SILC,
SNY,
SPNS,
SPSN,
SRA,
SVNT,
TARO,
TATT,
TEVA,
TFR,
TISA,
TLAB,
TSEM,
TSM,
TTIL,
ULCM.PK,
VRNT,
VYYO,
WILC,
ZRAN
- DSPG: Will Monday's Deal Herald A Breakthrough?
- Analysts Catching On Only Now, But Teva Has Always Been Heading North
- Taro Pharmaceutical: One for Speculators
- Sidelining Saifun: No Pleasant Surprises, But I'm Following It Closely
- Chairman Makov Rises to the Given Imaging Challenge
- Ormat: Time Will Tell Whether the Warning Was A One-time Event
- Why Are Analysts Lukewarm on Check Point?
- Zeroing In On Zoran: A Company Capable of Holding Its Own
- Everybody's Getting High on Pharmos, But The Stampede Is No Hint to Hold
- Taro Pharmaceutical: A Bargain May Be Beckoning
- Alvarion: Sentiment Progressively More Positive, And With Good Reason
- BluePhoenix: On The Rise
- TAT's Solid Growth Expected to Continue
- Commtouch: A Speculative Stock With Strong Management
- ECI Telecom: Wait on the Sidelines
- Pointer Telocation: Investment by Three Reputable Institutions Is Telling
- Protalix BioTherapeutics: This Dream Could Take Time to Manifest
- Alon USA Energy: It's All About the Management
- AudiCodes: VoIP May Be in Freefall, But This Stock Should Get a Second Look
- Elbit Medical Imaging: A Supplier of Dreams
-
Ampal-American Israel Corporation: Ample Opportunity to Soar
on Mon, Apr 9, 2007 • Comment!
- Rosetta Genomics: Can This Dream Team Woo Wall Street?
- Cimatron's Connection: Stock Soared Following Foray into China
- Retalix: Deal with British Petroleum is Tribute to the Company's Vision
- Eltek: Price Levels That Demand Attention
- Comverse: Price Levels That Demand Attention
- The Burden of Proof Is On Vyyo
- The Long Case for Deltathree: Stock Looks Cheap Compared to Performance
- A Mysterious Changing of the Guard: Is There Something ECtel's Not Telling?
- Teva: Making a Foray into Biogenerics?
- Silicom Makes Its Quantum Leap
- Elbit Systems: Ongoing Privatization Should Lead It to Victory
